Samarium-153 EDTMP Bone Pain Palliation Market to Reach USD 320 Million by 2034
  Global Samarium-153 EDTMP Bone Pain Palliation Radiopharmaceutical Market size was valued at USD 0.18 billion in 2025. The market is projected to grow from USD 0.19 billion in 2026 to USD 0.32 billion by 2034, exhibiting a CAGR of 6.7% during the forecast period. Samarium-153 EDTMP, also known as samarium-153 lexidronam or Quadramet®, is a beta‑emitting radiopharmaceutical...
0 Comentários 0 Compartilhamentos 6 Visualizações 0 Anterior
Patrocinado

Boosted Post #39817

FOUNDING CITIZENS PROGRAM The first active members of each AmarsCity District will receive: Founding Citizen Badge Early Recognition Priority Spotlight Features Future Reward Benefits...